Notably, HEY1 has been reported to be upregulated in 42.6% of HCC tumours in a cohort of 58 samples [15] and in 72.4% of cases in an expanded in-house cohort of 87 HCC patients [13]. Here, HEY1 is linked to hepatocellular carcinoma.